Form 4 Tracker
Anika Therapeutics, Inc.
ANIK

18 insider filings · Latest: Aug 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 7, 2026Aug 7 9:28 PMJellison William R
Proposed Sale
16,864$21.07$355.3K—

View →

Aug 4, 2026Aug 5 8:30 PMGary P FischettiDirector
Purchase
1,000$20.32$20.3K54,015(D)

View →

Aug 3, 2026Aug 5 8:30 PMGary P FischettiDirector
Purchase
1,000$20.75$20.7K53,015(D)

View →

May 1, 2026May 4 12:34 PMJohn B Henneman IIIDirector
Purchase
5,000$14.66$73.3K54,871(D)

View →

Apr 30, 2026Apr 30 9:22 PMStephen D. GriffinDirector, President and CEO
Purchase
12,200$12.29$149.9K36,163(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 3, 2026Jun 5 8:05 PMStephen D. GriffinDirector, President and CEO
Option Exercise
12,840—12,840(D)

View →

Mar 19, 2026Mar 23 9:23 PMIan McleodSVP, CAO & Treasurer
Grant/Award
41,954$15.6017,663(D)

View →

Mar 15, 2026Mar 17 11:47 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
6,449—6,448(D)

View →

Mar 14, 2026Mar 17 11:47 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
9,388—18,777(D)

View →

Mar 14, 2026Mar 17 11:44 PMStephen D. GriffinDirector, President and CEO
Option Exercise
12,824—25,649(D)

View →

Mar 15, 2026Mar 17 11:42 PMCheryl R BlanchardDirector
Option Exercise
25,131—25,132(D)

View →

Mar 14, 2026Mar 17 11:42 PMCheryl R BlanchardDirector
Option Exercise
24,519—49,040(D)

View →

Mar 15, 2026Mar 17 11:39 PMIan McleodSVP, CAO & Treasurer
Option Exercise
2,658—2,659(D)

View →

Mar 14, 2026Mar 17 11:39 PMIan McleodSVP, CAO & Treasurer
Option Exercise
3,774—7,550(D)

View →

Mar 9, 2026Mar 11 8:25 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
5,465—0(D)

View →

Mar 9, 2026Mar 11 8:24 PMCheryl R BlanchardDirector
Option Exercise
20,001—0(D)

View →

Mar 9, 2026Mar 11 8:24 PMIan McleodSVP, CAO & Treasurer
Option Exercise
2,197—0(D)

View →

Feb 1, 2026Feb 3 11:45 PMStephen D. GriffinDirector, President and CEO
Grant/Award
440,609—130,402(D)

View →